Medical Scientist Training Program (MSTP)

Medical Scientist Training Program

Thesis Defense

Featured Student

uploadedImages/education/mstp/featured-students/stefanie-rader.jpg

Stefanie Rader

The MSTP anatomy class is great. We have a 1:4 ratio of faculty to students in lab and 1:12 in lectures. We get personalized attention from the faculty, and the timing of the course allows us to take graduate school courses during the first year of the program.

 

The Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine (Einstein) is one of the nation’s oldest. From the start, our goal has been to train a diverse group of outstanding students to become future leaders of academic medicine and medical research. Continuously funded by the National Institutes of Health since 1964, the Einstein MSTP has 464 illustrious Alumni with careers spanning the spectrum from basic science research to clinical medicine and many variations in between.

Today, the Einstein MSTP is still unique. Larger than most other MSTPs, it fosters a strong academic and social community within the college. While large enough to be an independent academic unit, the program is still small enough to provide students with the individual attention their unique careers require.

The current training program recognizes that the successful physician-scientist training is not simply medical school plus graduate training. The program integrates MSTP-specific courses with medical and graduate courses, during the first two years of preclinical course work. Integration continues in the PhD thesis years through weekly involvement in the MSTP Continuity Clinic and monthly Clinical Pathological Conferences and MSTP Career Paths seminars.

Students have outstanding publications and residency placements.

The Einstein MSTP encourages applications from all individuals. As stated in the College's Diversity and Inclusion Strategic Plan for Excellence, "At Einstein, we value all people and perspectives that make us unique and increase our diversity at large. Albert Einstein College of Medicine reaffirms its commitment to recruiting, retaining and advancing individuals from historically underrepresented and marginalized minority groups in the scientific and medical professions. At the College of Medicine, this includes, (in no particular order, and is not limited to) women, individuals who are black, Latino/Latina; Pacific Islander or indigenous Americans; individuals from new immigrant populations; individuals with both apparent and nonapparent disabilities; all sexual and gender minorities, including lesbian, gay, bisexual, asexual and queer people as well as transgender, gender-nonconforming and intersex individuals; religious minorities and individuals from economically disadvantaged backgrounds."

Four M.D./Ph.D. students share what motivates them to pursue the long and rigorous course to become physician-scientists.  

Awards & Accomplishments

  • Michelle Gulfo NIH NRSA F31 Fellowship for a project entitled "Assessing dopaminergic modulation of an associative circuit within the dentate gyrus" (Sponsor, Pablo Castillo, Neuroscience)
  • Meera Trivedi NIH NRSA F31 Fellowship for a project entitled "Characterizing Novel Regulations of Dendritic Tiling in C. elegans" (Sponsor, Hannes Buelow, Neuroscience)
  • Jamie Moore NIH NRSA F31 Fellowship for a project entitled "Unraveling Mechanisms of Plasmacytoid Dendritic Cell Priming by CD169+ Macrophages in Severe Murine Malaria" (Sponsor, Gregoire Lauvau, Microbiology & Immunology)
  • Adam Spitz NIH NRSA F30 Fellowship for a project entitled "Direct Small Molecule Activation of Pro-apoptotic BAK" (Sponsor, Evris Gavathiotis, Biochemistry)
  • Hayden Hatch NIH NRSA F31 Fellowship for a project entitled "Transcriptional regulation, neuronal development, and function of the mushroom body in a Drosophila model of intellectual disability" (Co-Sponsors, Julie Secombe and Nicholas Baker, Neuroscience/Genetics)
  • Erik Hasenoehrl NIH NRSA F30 Fellowship for a project entitled "Targeting terminal respiratory oxidation in Mycobacterium tuberculosis: A novel investigation of Cytochrome bd oxidase function" (Co-Sponsors, Michael Berney & William Jacobs, Microbiology & Immunology)
  • Joshua Mayoral NIH NRSA F31 Fellowship for a project entitled "Secreted effectors of Toxoplasma gondii bradyzoites" (Sponsor, Louis Weiss, Pathology)
  • Joshua Weinreb NIH NRSA F30 Fellowship for a project entitled "Uncovering the Role of the DEAD Box Helicase Ddx41 in Hematopoiesis" (Sponsor, Teresa Bowman, Developmental & Molecular Biology)
  • Rosiris Leon-Rivera NIH NRSA F31 Fellowship for a project entitled "Molecular Mechanisms of Increased Risk of Racial and Ethnic Minorities for HIV Associated Neurocognitive Disorders" (Sponsor, Joan Berman, Pathology)
  • Todd Rubin NIH NRSA F31 Fellowship for a project entitled "Examining sex as a predictor of outcomes across multiple levels of head trauma" (Sponsor, Michael Lipton, Neuroscience)
  • Niloy Iqbal NIH NRSA F30 Fellowship for a project entitled "Tumor Suppressor pRb is a Novel Target for Hypothalamic Inhibition of Diet Induced Obesity" (Sponsors, Liang Zhu and Streamson Chua, Jr., Developmental & Molecular Biology)
  • Kristin Palarz NIH NRSA F31 Fellowship for a project entitled "Serotoninergic modulation of cerebellar circuitry" (Sponsor, Kamran Khodakhah, Neuroscience)
  • Peter John NIH NRSA F30 Fellowship for a project entitled "B7x in Cancer: Mechanisms and Therapies" (Sponsor, XingXing Zang, Microbiology & Immunology)
  • Richard Piszczatowski NIH NRSA F30 Fellowship for a project entitled "Investigating the role of Nol3 in normal and malignant hematopoiesis" (Sponsor, Ulrich Steidl, Cell Biology)
  • Liane Hunter NIH NRSA F31 Fellowship for a project entitled "Identifying Biomarkers that Modify Outcomes in Soccer Heading" (Sponsor, Michael Lipton, PhD in Clinical Investigation)
  • Justin Wheat NIH NRSA F30 Fellowship for a project entitled "Uncovering Transcriptional Regulation of a Master Hematopoietic Transcription Factor at Single Molecule Resolution" (Sponsor, Ulrich Steidl & Robert Singer, Cell Biology and Anatomy & Structural Biology)
  • Jeet Biswas NIH NRSA F30 Fellowship for a project entitled "The sequence recognition, structure and function of the IMP family of mRNA binding proteins" (Sponsor, Robert Singer, Anatomy & Structural Biology)
  • Sean Healton NIH NRSA F30 Fellowship for a project entitled "Epigenetic activity of normal and cancer-associated mutant H1 linker histones" (Sponsor, Arthur Skolutchi, Cell Biology)
  • Cary Weiss NIH NRSA F30 Individual for a project entitled "MicroRNA-22 and the microRNA-22/tet2 network as regulators of the cell fate decision in hematopoietic stem cells and in the development of myelodysplastic syndrome" (Sponsor, Keisuke Ito, Cell Biology)
  • Ruth Howe, NIH NRSA F30 Fellowship for a project entitled "Characterizing the Novel Protein C15ORF65" (Sponsor,  Ulrich Steidl, Cell Biology)
  • Marika Osterbur, NIH NRSA F30 Fellowship for a project entitled "Extra-coding features of mRNA are essential for hERG channel function" (Sponsor, Thomas McDonald, Molecular Pharmacology)
  • Karin Skalina, NIH NRSA F30 Fellowship for a project entitled "Optimization of non-ablative focused ultrasound therapy for tumor immunity" (Sponsor, Chandan Guha, Pathology)
  • Michael Willcockson, NIH NRSA F30 Fellowship for a project entitled "Regulators of the erythroid terminal differentiation decision and their connection to the cell cycle" (Sponsor, Art Skoultchi, Cell Biology)
  • Nelson Gil, NIH NRSA F31 Fellowship for a project entitled "The molecular basis of receptor-ligand recognition on the immunological synapse" (Sponsor, Andras Fiser, Systems & Computational Biology)

 more awards 

Publications

  • publications Khan S, Kelly L. Multiclass Disease Classification from Microbial Whole-Community Metagenomes. Pac Symp Biocomput. 2020
  • publications Diacou R, Bhansali P, Liu W. Three-Dimensional Culture of Mouse Eyecups. Methods Mol Biol. 2020
  • publications Mayoral J, Di Cristina M, Carruthers VB, Weiss LM. Toxoplasma gondii: Bradyzoite Differentiation In Vitro and In Vivo. Methods Mol Biol. 2020
  • publications Malonis RJ, Lai JR, Vergnolle O. Peptide-Based Vaccines: Current Progress and Future Challenges. Chem Rev. 2019 Dec 5
  • publications Savage T, Pandey S, Guha C. Post-ablation modulation after single high-dose radiation therapy improves tumor control via enhanced immunomodulation. Clin Cancer Res. 2019 Nov 22
  • publications Klein ME, Younts TJ, Cobo CF, Buxbaum AR, Aow J, Erdjument-Bromage H, Richard S, Malinow R, Neubert TA, Singer RH, Castillo PE, Jordan BA. Sam68 Enables Metabotropic Glutamate Receptor-Dependent LTD in Distal Dendritic Regions of CA1 Hippocampal Neurons. Cell Rep. 2019 Nov 12
  • publications Quiroz JA, Malonis RJ, Thackray LB, Cohen CA, Pallesen J, Jangra RK, Brown RS, Hofmann D, Holtsberg FW, Shulenin S, Nyakatura EK, Durnell LA, Rayannavar V, Daily JP, Ward AB, Aman MJ, Dye JM, Chandran K, Diamond MS, Kielian M, Lai JR. Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins. PLoS Pathog. 2019 Nov 7
  • publications Skalina KA, Singh S, Chavez CG, Macian F, Guha C. Low Intensity Focused Ultrasound (LOFU)-mediated Acoustic Immune Priming and Ablative Radiation Therapy for in situ Tumor Vaccines. Sci Rep. 2019 Oct 29
  • publications Iqbal N, Zhu L, Chua SC Jr. Neuronal Cell Cycle Events Link Caloric Intake to Obesity. Trends Endocrinol Metab. 2019 Oct 16.
  • publications Biswas J, Patel VL, Bhaskar V, Chao JA, Singer RH, Eliscovich C. The structural basis for RNA selectivity by the IMP family of RNA-binding proteins. Nat Commun. 2019 Sep 30
  • publications Hasenoehrl EJ, Rae Sajorda D, Berney-Meyer L, Johnson S, Tufariello JM, Fuhrer T, Cook GM, Jacobs WR Jr, Berney M. Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection. Nat Commun. 2019 Sep 16
  • publications Brace KM, Lee WW, Cole PD, Sussman ES. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation. J Clin Exp Neuropsychol. 2019 Oct
  • publications Huang MW, Stock AD, Mike EV, Herlitz L, Kolbeck R, Putterman C. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/lpr lupus mice. Lupus. 2019 Aug 31
  • publications Willcockson MA, Taylor SJ, Ghosh S, Healton SE, Wheat JC, Wilson TJ, Steidl U, Skoultchi AI. Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation. Proc Natl Acad Sci U S A. 2019 Aug 20

more publications 

Click here to log in
Medical Scientist Training Program (MSTP)